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Abstract. Multiple gland parathyroid disease is one of the hallmarks of
multiple endocrine neoplasia (MEN) type 1. Often mislabeled parathyroid
hyperplasia, the process is actually the development of multiple adenomas.
Some clinicians have reported results of selective parathyroidectomy in
this group, removing only grossly enlarged glands. We argue that all the
glands are at risk and should be addressed at any planned parathyroid
intervention. Our hypothesis is that, given sufficient time, patients would
all develop adenomas in each of the parathyroid glands. Our available data
to address this issue are the parathyroidectomy results from a single insti-
tution series. Patients who had initial parathyroid exploration for hyper-
parathyroidism in the setting of MEN-1 were reviewed. This study includes
those patients who had the weights of the resected glands documented; 23
men and 21 women met the criteria. The total weight of the parathyroid
glands did not vary with the age of the patient at operation. However, the
number of normal glands identified did vary significantly with age (p <
0.02), with older patients being less likely to have any normal parathyroid
glands. Although total parathyroid weight may correlate with development
of hypercalcemia and indications for operation, the involvement of mul-
tiple parathyroid glands in MEN-1 is a function of time, as independent
events in each gland must occur. Given time, MEN-1 patients all develop
multiple gland disease, and this reality must be used in planning operative
management for patients with this syndrome.
Multiple gland parathyroid disease is the most frequently ex-
pressed of the classic features of multiple endocrine neoplasia type
1 (MEN-1), and it is often asymmetric [1]. Although some authors
in the past have proposed strategies that address only glands that
are grossly enlarged at operation [2], most now agree that any op-
eration for hyperparathyroidism in these patients should address
all of the parathyroid glands, because they all may eventually be-
come abnormally enlarged and cause hypercalcemia. The generally
accepted operative options include subtotal parathyroidectomy
and total parathyroidectomy with a parathyroid autograft to ad-
dress the multiple gland disease [3–6].
The nature of multiple-gland disease (MGD) in MEN-1 is dif-
ferent from other frequently treated MGD situations, such as the
parathyroid hyperplasia leading to renal osteodystrophy. In the
past some investigators have proposed that there is a circulating
factor in MEN-1 that causes parathyroid hyperplasia [7]. However,
other evidence regarding the clonality of parathyroid adenomas
has indicated that this is a neoplastic process rather than a hyper-
plastic process [8, 9]. These data imply that the germline mutation
in MEN-1 allows the development of multiple parathyroid adeno-
mas, a process that requires discrete second events in each para-
thyroid gland. We hypothesized that the probability of the “second
hit” occurring in any individual parathyroid gland would increase
with time, and thus the likelihood of having any normal parathyroid
glands would decrease with age. The chance of having a second hit
occur in each of the parathyroid glands simultaneously would also
seem to be low. The difference in the time at which these events
occur seems likely to cause the development of asymmetrical gland
enlargement, as the multiple independent parathyroid adenomas
each begin development at different times. Here we report the
parathyroid gland weights for 44 MEN-1 patients who underwent
their initial parathyroid operation at Washington University in St.
Louis, MO, USA, and who had the gland weights documented, to
evaluate our hypothesis.
Materials and Methods
MEN-1 kindred members treated at Washington University are
followed through the Multiple Endocrine Neoplasia Program, and
their clinical data are maintained in a prospective database as a part
of an IRB-approved research program. Patients who had their ini-
tial parathyroidectomy at Washington University were extracted
from the database, and those who had parathyroid gland weight
documented were included in this study. Each patient had the di-
agnosis of hyperparathyroidism confirmed by simultaneous eleva-
tions of serum levels of calcium and parathyroid hormone. Opera-
tive exploration was carried out via a standard approach designed
to identify all parathyroid tissue within the neck and anterior me-
diastinum. All patients had a transcervical thymectomy as a part of
the exploration, to remove all accessible thymus tissue, and any
parathyroid tissue contained within the thymus. Patients had either
total parathyroidectomy with autograft, or subtotal parathyroidec-
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tomy, as selected according to surgeon and patient preference. For
patients who had subtotal parathyroidectomy, 60–100 mg of the
most normal-appearing gland was preserved on its native blood
supply prior to removing the remaining glands. For those patients
who had total parathyroidectomy and autograft, 60–100 mg of the
most normal-appearing gland were autografted, generally into the
brachioradialis muscle of the non-dominant forearm. Gland
weights were determined as wet-weight in the operating room im-
mediately upon excision of the gland, performed sterilely on a digi-
tal scale. Age, total parathyroid gland weight, individual gland
weights, and number of normal glands (< 65 mg) were correlated
and trends evaluated by regression analysis with significance de-
fined as p < 0.05.
Results
Twenty-three men and 21 women, ranging in age from 13 to 57
years met the criteria for inclusion. The individual gland weights for
each patient are given in Figure 1. In this series, 39 of 44 patients
had four glands identified at these initial operations. The remain-
ing five patients each had three glands identified. Although some
glands were identified within the superior portions of the thymus,
all glands were located in typical locations for parathyroid glands.
There were no patients with supernumerary glands identified, ei-
ther within the removed thymus or elsewhere. Except for deliber-
ately preserved parathyroid remnants in the patients who had sub-
total parathyroidectomy, every effort was made to remove all of
each patient’s parathyroid tissue.
Patients had great variability in the size of their individual para-
thyroid glands, confirming the asymmetry of involvement. The total
weight of the parathyroid glands at operation (sum of the weights of
the individual glands) is depicted in Figure 2. The total weight did
not vary with the age of the patient at operation. However, the
number of normal glands identified did vary significantly with age
(regression analysis, p < 0.02), with older patients being less likely
to have any normal parathyroid glands (Fig. 3).
Discussion
The germline abnormality in MEN-1 is present in each cell of the
body; however, disabling changes in the normal copy of MEN1 that
occur in the endocrine pancreas, pituitary, and parathyroid glands
(as well as other less common sites) cause the development of mul-
tiple adenomas. The nature of the “second hits” leading to para-
thyroid adenomas dictates that not every parathyroid gland is af-
fected identically or simultaneously, thus leading to the marked
asymmetry that has been observed by many surgeons [1]. While
total parathyroid weight may correlate with development of hyper-
calcemia and indications for operation, the parallel involvement of
multiple parathyroid glands in MEN-1 is a function of time, as in-
dependent events in each gland must occur.
The important findings in this series include confirmation of the
asymmetry of the parathyroid adenomas in MEN-1, and demon-
Fig. 1. Parathyroid weights versus patient age. The weights of the indi-
vidual parathyroid glands are plotted in log scale versus the age of the pa-
tient at the time of operation. The upper limit of the weight of normal
glands is designated as 65 mg. The parathyroid glands from an individual
patient are connected by a solid line; however, in all cases where there is
more than one patient for a given age, there is overlap of the connecting
lines.
Fig. 2. Total parathyroid weight at the time of operation versus patient
age. Each dot represents the summed weights of the parathyroid glands of
an individual patient. There was no correlation between the age of the pa-
tient at operation and the weight of the parathyroid glands.
Fig. 3. Number of normal parathyroid glands versus patient age. Each dot
represents the number of normal parathyroid glands (weight < 65 mg) iden-
tified at operation. There was a negative correlation between the number of
normal glands and age (p < 0.02).
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stration of the relationship between age and the likelihood of
identifying any normal parathyroid glands. The asymmetry of the
parathyroid glands in MEN-1 has been commented on by others,
and it has been studied in a similar fashion, using parathyroid
volume, by the United States National Institutes of Health (NIH)
group [1]. The asymmetry itself did not vary with patient age
(Fig. 1), as patients at all ages had glands of varying sizes, a finding
similar to those in the NIH study. These data fit with the observa-
tions of many surgeons, and this is the observation that led some
in the past to propose more limited operative resection for MEN-1
parathyroid disease. Interestingly, in spite of the progression in
the number of abnormal glands with age, the total weight of the
parathyroid glands did not change significantly with age (Fig. 2).
Finally, the likelihood of involvement of each of the parathyroid
glands increased with increasing patient age (Fig. 3). This fits
well with the hypothesis that independent second hits are necessary
for the development of each parathyroid adenoma. The chance of
this event having occurred in any one parathyroid gland in any pa-
tient should increase with age, and it appears to, according to these
data.
The asymmetry of parathyroid gland involvement in MEN-1 led
some clinicians to suggest a selective approach to parathyroidecto-
my, removing only the glands observed to be enlarged at the time
of operation [2]. Biologically and clinically, this has not seemed a
rational strategy to us. Our working hypothesis of MEN-1 is
that, given time, MEN-1 patients all develop multiple gland dis-
ease, and this reality must be used in planning operative manage-
ment of patients with this syndrome. This study demonstrates the
data behind that approach, and confirms our understanding of the
pathophysiology of MEN-1 parathyroid disease. As age increases,
the number of normal parathyroid glands decreases. Thus, in our
opinion, and given the potential morbidity of secondary operations
in the neck, any operation to address the parathyroid disease in
MEN-1 should address all of the parathyroid glands, whether they
appear normal or abnormal at the time of the operation. In addi-
tion, as a part of that strategy, we advocate removing the cervically
accessible thymus at the time of initial operation, to try to remove
all sites of parathyroid tissue, as well as to prevent the potential
future development of malignant thymoma as a component of
MEN-1.
The two operative strategies that are widely used (total parathy-
roidectomy with autograft, and subtotal parathyroidectomy) each
have their weaknesses and failures [4, 10–12]. Neither offers a per-
manent, reliable solution for the disease. The goal of each opera-
tion is to remove most of the parathyroid tissue, and to leave a
smaller fragment of functional tissue in a single, defined location.
Each operation recognizes the facts that (1) it is better to have a
smaller amount of abnormal parathyroid tissue than to have none
at all and (2) it is easier to address the recurrent disease if all of the
abnormal tissue is left in one place. Each of these operations can
fail if not all of the abnormal tissue is addressed at the initial op-
eration, leaving for instance, an abnormal gland that is unidentified
in the neck or thymus, or if the deliberately preserved tissue (on its
native blood supply or as an autograft) fails to function adequately.
Each approach is also expected to “fail” at a later date, as the para-
thyroid remnant (either in the neck or at the autograft site) can
grow, causing the hypercalcemia and hyperparathyroidism to recur
[10]. The optimal solution to this disease has not yet been devised,
but any potential intervention must address all of the parathyroid
glands to be durably successful.
Résumé. La maladie multiglandulaire est une des caractéristiques du
syndrome MEN-1. Souvent étiquetée à tort «hyperplasie» de la
parathyroı̈de, il s’agit en fait d’un stade de développement des adénomes
multiples. Certains cliniciens ont rapporté des résultats de la
parathyroı̈dectomie sélective chez ce groupe de patients, enlevant
seulement les glandes augmentées de volume macroscopiquement. Nous
pensons que toutes les glandes sont à risque et peuvent faire l’objet d’une
exérèse au cours d’une intervention sur la parathyroı̈de. Notre hypothèse
est qu’au fils du temps, les patients auraient tous développé un adénome de
chaque parathyroı̈de. Nous avons adressé cette hypothèse basée sur nos
propres données mono-institutionelles. Les dossiers des patients ayant eu
une exploration initiale de la parathyroı̈de pour hyperparathyroı̈die dans
le cadre d’un MEN-1 ont été passé en revue. Cette étude a inclus les patients
pour lesquels on a disposé du poids des glandes réséquées. Ont rempli les
critères d’inclusion, 23 hommes et 21 femmes. Le poids total des glandes
parathyroı̈des ne variaient pas avec l’âge au moment de l’intervention.
Cependant, le nombre de glandes normales identifiées était proportionnel
à l’âge (p < 0.02), avec les patients les plus âgés les moins susceptibles d
’avoir des glandes normales. Alors que le poids total des parathyroı̈des peut
corréler avec le développement de l’hypercalcémie et les indications pour
intervention, la multiplicité des glandes intéressées par le processus dans
le syndrome MEN-1 n’est qu’une question de temps, dépendant d’un
événement spécifique dans chaque glande. Après un délai suffisamment
long, les patients MEN-1 développent tous la maladie multiple et cet état de
connaissances doit intervenir dans la décision opératoire chez les patients
porteurs de ce syndrome.
Resumen. La enfermedad paratiroidea pluriglandular es una de las
caracterı́sticas del sı́ndrome de neoplasia endocrina múltiple (MEN-1).
Con frecuencia es erróneamente designada como hiperplasia paratiroidea,
cuando en realidad el proceso es el desarrollo de adenomas múltiples.
Algunos autores han informado los resultados de paratiroidectomı́a
selectiva, o sea la resección de sólo las glándulas macroscópicamente
hipertróficas en este grupo de pacientes. Nosotros creemos que todas las
glándulas se hallan en riesgo y que deben ser consideradas al planear una
intervención paratiroidea, bajo la hipótesis de que transcurrido un tiempo
suficiente, todos los pacientes desarrollarán adenomas en cada una de las
glándulas paratiroideas. Los datos pertinentes de que disponemos ahora
provienen de los resultados de una serie de paratiroidectomı́as realizadas
en una sola institución. Se revisaron las historias de los pacientes que
tuvieron una exploración paratiroidea inicial en el contexto de un MEN-1.
El estudio incluyó aquellos pacientes en que aparecı́a documentado el peso
de las glándulas resecadas. 23 hombres y 21 mujeres cumplieron los
criterios. El peso total de las glándulas paratiroideas no varió con la edad
del paciente en el momento de la operación. Sin embargo, el número de
glándulas normales identificadas sı́ varió en forma significativa con la
edad (p < 0.02), siendo los pacientes mayores quienes con menor
frecuencia presentaron alguna paratiroides normal. En tanto que el peso
paratiroideo total puede correlacionarse con el desarrollo de
hipercalcemia y las indicaciones para operación, la afección de múltiples
glándulas paratiroides en el MEN-1 es una función del tiempo, en la
medida que eventos independientes ocurren en cada glándula. Dado un
tiempo suficiente, todos los pacientes con MEN-1 desarrollan enfermedad
multiglandular, y tal realidad debe ser tenida en cuenta en la planeación
del manejo operatorio de pacientes con este sı́ndrome.
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